Company

Affluent Medical SA

Headquarters: Paris, France

Employees: 47

CEO: Mr. Michel Finance

Euronext: AFME -4.35%

Market Cap

€51.6 Million

EUR as of July 1, 2024

US$55.4 Million

Market Cap History

Affluent Medical SA market capitalization over time

Evolution of Affluent Medical SA market cap in the past 5 years

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Market Cap History of Affluent Medical SA

Detailed Description

Affluent Medical SA, a medical devices company, designs, develops, manufactures, and markets implantable prostheses devices in France. The company develops Kardiozis prosthesis for the noninvasive treatment of abdominal aortic aneurysm; Kalios and Epygon implants for the treatment of mitral insufficiency; and Artus implant, an artificial electromechanical implantable sphincter for severe urinary incontinence in women and men. The company was founded in 2011 and is headquartered in Aix-en-Provence, France.

Top 1-year algo backtest: +265.99%

$10,000 in October 2023 would now be $36,599 by following this algorithm daily at market close.

Use AI to boost your investing & swing trading, now!

Try Disfold DeepFinance FREE

Stocks & Indices

Affluent Medical SA has the following listings and related stock indices.


Stock: Euronext: AFME wb_incandescent

Stock: FSX: 0JZ wb_incandescent

Details

Headquarters:

5 rue de la Baume

Paris, 75008

France

Phone: 33 1 82 28 46 00